This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Sumitomo Pharmaceuticals Company Limited, Dainippon Sumitomo Pharma Co., Ltd.. Active years: 2000-2007.
Company Filing History:
2 out of 174 
1 out of 140 Years Active: 2000-2007
Title: The Innovations of Yoshihide Ueno
Introduction
Yoshihide Ueno is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that exhibit beneficial biological activities. With a total of 3 patents to his name, Ueno's work has garnered attention in the pharmaceutical industry.
Latest Patents
One of Ueno's latest patents involves the synthesis of indole, indazole, and benzazole derivatives. The compound of the formula (I) features a group of the following formula (VIII) that can bind to various positions on the Q. The Q is, together with W, a group of the formula: —C(W)≡C(R)—N(R)—, where R can be hydrogen or optionally substituted lower alkyl. These compounds are noted for their β3-adrenoceptor-stimulating activity and are useful as medicaments for the treatment of obesity, among other applications.
Career Highlights
Throughout his career, Ueno has worked with notable companies such as Sumitomo Pharmaceuticals Company Limited and Dainippon Sumitomo Pharma Co., Ltd. His expertise in medicinal chemistry has played a crucial role in advancing pharmaceutical research and development.
Collaborations
Ueno has collaborated with esteemed colleagues, including Koji Morishita and Naohito Ohashi. These partnerships have contributed to the successful development of innovative compounds and have furthered the impact of his research in the field.
Conclusion
Yoshihide Ueno's contributions to medicinal chemistry and his innovative patents highlight his role as a key figure in the pharmaceutical industry. His work continues to influence the development of new treatments and compounds that address significant health challenges.